Detalles de la búsqueda
1.
Inhibition of mTOR prevents glucotoxicity-mediated increase of SA-beta-gal, p16INK4a, and insulin hypersecretion, without restoring electrical features of mouse pancreatic islets.
Biogerontology
; 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38748336
2.
Comparative Screening of the Liver Gene Expression Profiles from Type 1 and Type 2 Diabetes Rat Models.
Int J Mol Sci
; 25(8)2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38673735
3.
Maize Flavonoid Biosynthesis, Regulation, and Human Health Relevance: A Review.
Molecules
; 27(16)2022 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36014406
4.
Combined Gamma Conglutin and Lupanine Treatment Exhibits In Vivo an Enhanced Antidiabetic Effect by Modulating the Liver Gene Expression Profile.
Pharmaceuticals (Basel)
; 16(1)2023 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36678614
5.
Glucokinase activation as antidiabetic therapy: effect of nutraceuticals and phytochemicals on glucokinase gene expression and enzymatic activity.
Arch Physiol Biochem
; 127(2): 182-193, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31210550
6.
Lupin γ-conglutin protects against cell death induced by oxidative stress and lipotoxicity, but transiently inhibits in vitro insulin secretion by increasing KATP channel currents.
Int J Biol Macromol
; 187: 76-90, 2021 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34280449
7.
Effect of the acute and chronic administration of Lupinus albus ß-conglutin on glycaemia, circulating cholesterol, and genes potentially involved.
Biomed Pharmacother
; 133: 110969, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33166762
8.
Lupin gamma conglutin protein: effect on Slc2a2, Gck and Pdx-1 gene expression and GLUT2 levels in diabetic rats
Rev. bras. farmacogn
; 28(6): 716-723, Nov.-Dec. 2018. tab, graf
Artículo
en Inglés
| LILACS | ID: biblio-977739
Resultados
1 -
8
de 8
1
Próxima >
>>